Compound 5i significantly up-regulated the expressions of p-Akt, which were translated by tumor suppress genes, and the levels of p-EGFR and Akt remained unchanged regardless of treatment with 5i or gefitinib at 10 μM. Here, EGFR is linked to neoplasm.